NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT01875237 2019-07-16Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide GeneM.D. Anderson Cancer CenterPhase 1/2 Terminated3 enrolled 15 charts
NCT00002831 2018-10-26Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute LeukemiaM.D. Anderson Cancer CenterPhase 1/2 Completed24 enrolled